Developer docs
API playgroundTry for free, no card

Search company profiles

Sivan Innovation

Full company profile

uuid000h5cn

Namestring
Sivan Innovation
Legal namestring
Sivan Innovation
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Sivan Innovation is an Israel-based medical technology company founded in 2014 that develops Moovcare, a regulated medical telesurveillance platform for adult cancer patients. The product operates through a web-based application on which patients complete weekly structured questionnaires via smartphone, tablet, or computer to report health status and symptoms. The submitted data is analyzed by a clinical algorithm and then reviewed by a dedicated in-house team of oncology-specialized physicians and nurses; when concerning signals are detected, the team contacts the patient and informs the treating oncologist to enable rapid intervention. The company holds Class IIa medical device status with CE marking under EU MDR in Europe and Class I medical device designation in Canada, positioning Moovcare as a prescription telesurveillance device rather than a wellness app.

Sivan offers three specialized product modules on top of the core platform: Moovcare (general cancer telemonitoring), Moovcare Poumon (lung cancer-specific monitoring), and Moovcare Toxicite (early detection of treatment-related toxicities), supplemented by a Soins de Support (supportive care) module that captures patient-reported well-being and returns personalized advice. The technology stack is essentially a structured patient-reported outcomes (PRO) capture system combined with algorithmic signal detection and human clinical review, with the company explicitly stating it does not interfere with the oncologist's therapeutic decisions. Clinical validation is the central evidence asset: studies on more than 3,000 patients have been published in peer-reviewed journals including the Journal of Thoracic, JNCI, JAMA, and ASCO, and a 2026 Institut Curie study reported that 94% of patients found the application easy to use. The company is privately held, with headquarters in Ra'anana, Israel, a French subsidiary (Sivan France) in Asnieres-sur-Seine, and EU Authorized Representation via Kapsicum in Saclay, France.

Sivan operates a subscription-based revenue model, selling Moovcare as a recurring telesurveillance medical device reimbursed in France under the national telesurveillance framework. The go-to-market motion is sales-led and focused on oncology teams and cancer treatment centers, with direct patient enrollment supported through the Moovcare website. The customer base spans 'thousands of patients' cumulatively across Israel, France, and Canada. Leadership comprises CEO Ayala Bliah and President/Founder Daniel Israel. The company has no public funding rounds, ownership disclosures, or revenue figures, and operates with 11-50 employees, indicating a small, founder-driven organization that has prioritized clinical evidence and regulatory certification over rapid headcount or capital scaling.

Short descriptiontext

Sivan Innovation is an Israel-based medical technology company that develops Moovcare, a CE-marked Class IIa telesurveillance medical device for adult cancer patients, combining weekly patient-reported questionnaires with algorithm-driven analysis and oncology-supervised monitoring across Israel, France, and Canada.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersParis, France
HQ citystring
Paris
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cancer telesurveillance, oncology remote monitoring, medical device software, patient symptom tracking, digital health oncology
Industry3 codes
PRIMARYHLALAFAD
Oncology Remote Symptom Monitoring & Care Navigation
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALAGAH
Oncology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLAKAFAL
Thoracic (Lung) Oncology
NAICS code1 code
  • Computer Systems Design and Related Services54151
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Services-Misc Health & Allied Services, Nec8090
Product category
Oncology Remote Patient Monitoring (Medical Device Software)
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Subscription
TypeSubscription Recurring
Description

Moovcare operates as a regulated medical device (Class IIa in Europe, Class I in Canada) sold through a subscription model to cancer patients under oncology team supervision. The solution is reimbursed as a telesurveillance medical device in France and operates in coordination with healthcare providers.

moovcare.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Pricing details1 tier
1Medical telesurveillance subscription for cancer patients
ModelSubscriptionBilling cadenceMonthly
Notes

Pricing details not publicly available. Quote-based sales model requiring contact with sales team.

moovcare.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1Moovcare
Description

Medical telemonitoring device for cancer patients, including Moovcare® Poumon (lung cancer telemonitoring) and Moovcare® Toxicité (treatment toxicity detection). Class IIa medical device with CE marking for Europe, Class I for Canada.

moovcare.com
Core offering1 text field

Sivan Innovation develops and sells Moovcare, a regulated medical telesurveillance device (Class IIa CE-marked in Europe, Class I in Canada) that monitors cancer patients between oncology consultations via weekly web-based questionnaires analyzed by a clinical algorithm and supervised by an oncology-specialist medical team. Specialized variants target lung cancer (Moovcare Poumon) and treatment-related toxicities (Moovcare Toxicité), with a Soins de Support module for supportive care.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 94% of patients find the application easy to use (clinical study, Institut Curie 2026)
+2 more records
Product overview1 text field

Sivan Innovation offers Moovcare, a suite of medical telemonitoring products designed for cancer patients. The core offering consists of Moovcare (general cancer telemonitoring) and two specialized solutions: Moovcare® Poumon for lung cancer patients and Moovcare® Toxicité for detecting treatment-related toxicities. All products operate through weekly patient questionnaires analyzed by algorithms and supervised by oncology medical teams, with the Soins de Support module providing additional supportive care recommendations. The solutions are Class IIa medical devices with CE marking (Europe) and Class I designation (Canada).

Product and service3 records
1Moovcare
CategoryCancer telesurveillance medical device software
Description

Class IIa CE-marked medical telesurveillance device for adult cancer patients under oncology team supervision. Enables weekly web-based symptom questionnaires analyzed by a clinical algorithm and supervised by an oncology-specialist medical team, which alerts the patient's oncologist when clinical signals require attention.

2Moovcare Poumon
CategoryLung cancer telesurveillance medical device software
Description

Web-application for personalized telemonitoring of patients with lung cancer, enabling early detection of relapses and complications related to lung cancer through weekly questionnaires reviewed by oncology specialists.

3Moovcare Toxicité
CategoryCancer treatment toxicity monitoring medical device software
Description

Web-application dedicated to early detection of toxicities related to anticancer treatments, leveraging the Moovcare weekly questionnaire and oncology-supervised analysis workflow to flag treatment side effects for rapid intervention.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-01
Description

Institut Curie conducted clinical research on Moovcare, including a study demonstrating that 94% of patients find the application easy to use. The partnership provides clinical validation and peer-reviewed evidence for the Moovcare solution.

2Kapsicum
Strategic tierCoreTypeImplementation/ SI/ Consulting Partner
Description

Kapsicum serves as the EU Authorized Representative for Sivan Innovation, located at 4 rue René Razel, 91400 Saclay, France. As EU REP, Kapsicum ensures regulatory compliance for medical devices distributed in the European market.

moovcare.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Huma is a regulated digital health platform offering remote patient monitoring across multiple therapeutic areas including oncology, representing an adjacent emerging player with broader scope but overlapping technology and regulatory positioning.

TypeBroad incumbent
Description

Varian, now part of Siemens Healthineers, provides oncology treatment software and increasingly patient-facing digital tools, positioning it as a broad incumbent capable of embedding symptom monitoring into its oncology care platform.

TypeDirect peer
Description

Navigating Cancer offers a patient-facing platform for cancer symptom tracking, education, and care team communication, addressing the same use case of continuous monitoring between oncology consultations that Moovcare serves.

TypeDirect peer
Description

Noona is an oncology patient engagement and symptom-tracking platform acquired by Elekta, offering direct overlap with Moovcare's cancer telemonitoring value proposition. It targets the same oncology teams and patient populations with a comparable PRO-based monitoring workflow.

5Carevive Systems
TypeDirect peer
Description

Carevive provides oncology-specific remote symptom monitoring and care management software to cancer centers, closely mirroring Moovcare's model of capturing patient-reported outcomes and triggering clinician intervention for cancer patients.

TypeEmerging player
Description

Kaia Health is a digital therapeutics company delivering regulated software medical devices via subscription, sharing Moovcare's model of selling app-based, clinically validated digital therapies to patients under medical supervision.

TypeDirect peer
Description

Voluntis develops regulated digital therapeutic software (SaMD) for chronic conditions, sharing Moovcare's positioning as a CE-marked, prescription-based software medical device with similar reimbursement-driven commercial dynamics.

TypeBroad incumbent
Description

Flatiron Health (Roche) provides oncology-specific electronic health records, analytics, and real-world data, and represents a broad incumbent that can extend into patient monitoring and evidence generation for oncology care pathways.

TypeBroad incumbent
Description

Elekta is a major oncology technology vendor (radiotherapy, software) that acquired Noona to extend into patient engagement. It represents the broader incumbent ecosystem Sivan competes against for oncology IT budgets and clinical workflow integration.

TypeEmerging player
Description

Caresense Health focuses on remote patient monitoring for oncology, addressing a similar use case to Moovcare for tracking symptoms and outcomes between visits, with comparable clinical evidence-driven positioning.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sivan Innovation

Oncology Remote Patient Monitoring (Medical Device Software)sivan-innovation.com

Sivan Innovation is an Israel-based medical technology company that develops Moovcare, a CE-marked Class IIa telesurveillance medical device for adult cancer patients, combining weekly patient-reported questionnaires with algorithm-driven analysis and oncology-supervised monitoring across Israel, France, and Canada.

What Sivan Innovation does

Sivan Innovation is an Israel-based medical technology company founded in 2014 that develops Moovcare, a regulated medical telesurveillance platform for adult cancer patients. The product operates through a web-based application on which patients complete weekly structured questionnaires via smartphone, tablet, or computer to report health status and symptoms. The submitted data is analyzed by a clinical algorithm and then reviewed by a dedicated in-house team of oncology-specialized physicians and nurses; when concerning signals are detected, the team contacts the patient and informs the treating oncologist to enable rapid intervention. The company holds Class IIa medical device status with CE marking under EU MDR in Europe and Class I medical device designation in Canada, positioning Moovcare as a prescription telesurveillance device rather than a wellness app.

Sivan offers three specialized product modules on top of the core platform: Moovcare (general cancer telemonitoring), Moovcare Poumon (lung cancer-specific monitoring), and Moovcare Toxicite (early detection of treatment-related toxicities), supplemented by a Soins de Support (supportive care) module that captures patient-reported well-being and returns personalized advice. The technology stack is essentially a structured patient-reported outcomes (PRO) capture system combined with algorithmic signal detection and human clinical review, with the company explicitly stating it does not interfere with the oncologist's therapeutic decisions. Clinical validation is the central evidence asset: studies on more than 3,000 patients have been published in peer-reviewed journals including the Journal of Thoracic, JNCI, JAMA, and ASCO, and a 2026 Institut Curie study reported that 94% of patients found the application easy to use. The company is privately held, with headquarters in Ra'anana, Israel, a French subsidiary (Sivan France) in Asnieres-sur-Seine, and EU Authorized Representation via Kapsicum in Saclay, France.

Sivan operates a subscription-based revenue model, selling Moovcare as a recurring telesurveillance medical device reimbursed in France under the national telesurveillance framework. The go-to-market motion is sales-led and focused on oncology teams and cancer treatment centers, with direct patient enrollment supported through the Moovcare website. The customer base spans 'thousands of patients' cumulatively across Israel, France, and Canada. Leadership comprises CEO Ayala Bliah and President/Founder Daniel Israel. The company has no public funding rounds, ownership disclosures, or revenue figures, and operates with 11-50 employees, indicating a small, founder-driven organization that has prioritized clinical evidence and regulatory certification over rapid headcount or capital scaling.

Sivan Innovation firmographics

Firmographics
Name
Sivan Innovation
Legal name
Sivan Innovation
Website
https://sivan-innovation.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
Sivan Innovation is an Israel-based medical technology company that develops Moovcare, a CE-marked Class IIa telesurveillance medical device for adult cancer patients, combining weekly patient-reported questionnaires with algorithm-driven analysis and oncology-supervised monitoring across Israel, France, and Canada.
Ownership category
akta.pro rank

Sivan Innovation industry classification

Industry
Product category
Oncology Remote Patient Monitoring (Medical Device Software)
NAICS
Computer Systems Design and Related Services (54151)
SIC
Surgical & Medical Instruments & Apparatus (3841), Services-Misc Health & Allied Services, Nec (8090)
akta.pro industry
PRIMARYHLALAFAD
Oncology Remote Symptom Monitoring & Care Navigation
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLALAGAH
Oncology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
SECONDARYHLAKAFAL
Thoracic (Lung) Oncology

Keywords

  • Cancer telesurveillance
  • Oncology remote monitoring
  • Medical device software
  • Patient symptom tracking
  • Digital health oncology

Where Sivan Innovation is headquartered

Location

Headquarters

HQ city
Paris
HQ country
France
HQ region
Europe

Offices3 records

Markets served

Sivan Innovation business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Device Subscription: Moovcare operates as a regulated medical device (Class IIa in Europe, Class I in Canada) sold through a subscription model to cancer patients under oncology team supervision. The solution is reimbursed as a telesurveillance medical device in France and operates in coordination with healthcare providers.

Pricing tiers

ModelBillingPrice
SubscriptionMonthlyMedical telesurveillance subscription for cancer patients

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Sivan Innovation product offering

Product offering

Core offering

Sivan Innovation develops and sells Moovcare, a regulated medical telesurveillance device (Class IIa CE-marked in Europe, Class I in Canada) that monitors cancer patients between oncology consultations via weekly web-based questionnaires analyzed by a clinical algorithm and supervised by an oncology-specialist medical team. Specialized variants target lung cancer (Moovcare Poumon) and treatment-related toxicities (Moovcare Toxicité), with a Soins de Support module for supportive care.

Product overview

Sivan Innovation offers Moovcare, a suite of medical telemonitoring products designed for cancer patients. The core offering consists of Moovcare (general cancer telemonitoring) and two specialized solutions: Moovcare® Poumon for lung cancer patients and Moovcare® Toxicité for detecting treatment-related toxicities. All products operate through weekly patient questionnaires analyzed by algorithms and supervised by oncology medical teams, with the Soins de Support module providing additional supportive care recommendations. The solutions are Class IIa medical devices with CE marking (Europe) and Class I designation (Canada).

Differentiator

Problem solved

Functional benefit

Brands

  • Moovcare: Medical telemonitoring device for cancer patients, including Moovcare® Poumon (lung cancer telemonitoring) and Moovcare® Toxicité (treatment toxicity detection). Class IIa medical device with CE marking for Europe, Class I for Canada.

Products and services

  • Moovcare Class IIa CE-marked medical telesurveillance device for adult cancer patients under oncology team supervision. Enables weekly web-based symptom questionnaires analyzed by a clinical algorithm and supervised by an oncology-specialist medical team, which alerts the patient's oncologist when clinical signals require attention.
  • Moovcare Poumon Web-application for personalized telemonitoring of patients with lung cancer, enabling early detection of relapses and complications related to lung cancer through weekly questionnaires reviewed by oncology specialists.
  • Moovcare Toxicité Web-application dedicated to early detection of toxicities related to anticancer treatments, leveraging the Moovcare weekly questionnaire and oncology-supervised analysis workflow to flag treatment side effects for rapid intervention.

Quantifiable outcome

  • 94% of patients find the application easy to use (clinical study, Institut Curie 2026)
  • +2 more outcomes

Companies that use Sivan Innovation

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles2 records

Sivan Innovation technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature4 records

Sivan Innovation partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Institut CuriecoreStrategic or Co-development Partner · 1 January 2026Institut Curie conducted clinical research on Moovcare, including a study demonstrating that 94% of patients find the application easy to use. The partnership provides clinical validation and peer-reviewed evidence for the Moovcare solution.
  • KapsicumcoreImplementation/ SI/ Consulting PartnerKapsicum serves as the EU Authorized Representative for Sivan Innovation, located at 4 rue René Razel, 91400 Saclay, France. As EU REP, Kapsicum ensures regulatory compliance for medical devices distributed in the European market.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Sivan Innovation competitors and assessment

Company assessment

Emerging players

  • Huma Therapeutics: Huma is a regulated digital health platform offering remote patient monitoring across multiple therapeutic areas including oncology, representing an adjacent emerging player with broader scope but overlapping technology and regulatory positioning.
  • Kaia Health: Kaia Health is a digital therapeutics company delivering regulated software medical devices via subscription, sharing Moovcare's model of selling app-based, clinically validated digital therapies to patients under medical supervision.
  • Caresense Health: Caresense Health focuses on remote patient monitoring for oncology, addressing a similar use case to Moovcare for tracking symptoms and outcomes between visits, with comparable clinical evidence-driven positioning.

Broad incumbents

  • Varian (Siemens Healthineers): Varian, now part of Siemens Healthineers, provides oncology treatment software and increasingly patient-facing digital tools, positioning it as a broad incumbent capable of embedding symptom monitoring into its oncology care platform.
  • Flatiron Health: Flatiron Health (Roche) provides oncology-specific electronic health records, analytics, and real-world data, and represents a broad incumbent that can extend into patient monitoring and evidence generation for oncology care pathways.
  • Elekta: Elekta is a major oncology technology vendor (radiotherapy, software) that acquired Noona to extend into patient engagement. It represents the broader incumbent ecosystem Sivan competes against for oncology IT budgets and clinical workflow integration.

Direct peers

  • Navigating Cancer: Navigating Cancer offers a patient-facing platform for cancer symptom tracking, education, and care team communication, addressing the same use case of continuous monitoring between oncology consultations that Moovcare serves.
  • Noona Healthcare (Elekta): Noona is an oncology patient engagement and symptom-tracking platform acquired by Elekta, offering direct overlap with Moovcare's cancer telemonitoring value proposition. It targets the same oncology teams and patient populations with a comparable PRO-based monitoring workflow.
  • Carevive Systems: Carevive provides oncology-specific remote symptom monitoring and care management software to cancer centers, closely mirroring Moovcare's model of capturing patient-reported outcomes and triggering clinician intervention for cancer patients.
  • Voluntis (Aptar Digital Health): Voluntis develops regulated digital therapeutic software (SaMD) for chronic conditions, sharing Moovcare's positioning as a CE-marked, prescription-based software medical device with similar reimbursement-driven commercial dynamics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Sivan Innovation social profiles

Digital presence

Sivan Innovation compliance and trust

Trust signal

Compliance4 records

Sivan Innovation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sivan Innovation leadership team

Management profile

Number of profiles

Profiles2 records

Sivan Innovation subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Sivan Innovation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sivan Innovation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sivan Innovation

What does Sivan Innovation do?

Sivan Innovation develops and sells Moovcare, a regulated medical telesurveillance device (Class IIa CE-marked in Europe, Class I in Canada) that monitors cancer patients between oncology consultations via weekly web-based questionnaires analyzed by a clinical algorithm and supervised by an oncology-specialist medical team. Specialized variants target lung cancer (Moovcare Poumon) and treatment-related toxicities (Moovcare Toxicité), with a Soins de Support module for supportive care.

Is Sivan Innovation a public or private company?

Sivan Innovation is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Sivan Innovation founded?

Sivan Innovation was founded in 2014. It employs 11 to 50 people.

Where is Sivan Innovation based?

Sivan Innovation is headquartered in Paris, France, in the Europe region.

How does Sivan Innovation make money?

One revenue line is on record: medical Device Subscription.

Who are Sivan Innovation's main competitors?

Emerging players on record are Huma Therapeutics, Kaia Health and Caresense Health. Broad incumbents are Varian (Siemens Healthineers), Flatiron Health and Elekta. Direct peers are Navigating Cancer, Noona Healthcare (Elekta), Carevive Systems and Voluntis (Aptar Digital Health).

Does Sivan Innovation have an API?

No public API is recorded for Sivan Innovation.

What industry is Sivan Innovation in?

Sivan Innovation's product category is Oncology Remote Patient Monitoring (Medical Device Software). Its primary akta.pro industry code is HLALAFAD, Oncology Remote Symptom Monitoring & Care Navigation, with a secondary code of HLALAGAH, Oncology Telemedicine Platforms. Its NAICS code is 54151 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals